CLINICAL_TRIALS
ClinicalTrials.gov record update
Immunogenicity and Safety of AVAXIM™ 80U-Pediatric Administered Alone or Concomitantly With TRIMOVAX™ in 12-13 Months Old Healthy Hepatitis A Seronegative Turkish Children
This page presents selected fields from the linked source record. It does not add a medical interpretation.
Record identity and dates
- Source
- ClinicalTrials.gov
- Source record ID
- NCT00313950
- Title field or adapter rule
- protocolSection.identificationModule.officialTitle
- Ingested At
- 2026-04-28T10:35:33.583107+00:00
- Published At
- 2014-01-22T00:00:00+00:00
- Record Updated At
- 2014-01-22
- Timestamp Basis
- source retrieval time was not retained by the feed adapter
- Date limitation
- source retrieval time was not retained by the feed adapter
Fields recorded by this source
- protocolSection.conditionsModule.conditions
["Measles", "Mumps", "Rubella", "Hepatitis A"]- protocolSection.statusModule.lastUpdatePostDateStruct.date
"2014-01-22"- protocolSection.identificationModule.nctId
"NCT00313950"- protocolSection.identificationModule.officialTitle
"Immunogenicity and Safety of AVAXIM\u2122 80U-Pediatric Administered Alone or Concomitantly With TRIMOVAX\u2122 in 12-13 Months Old Healthy Hepatitis A Seronegative Turkish Children"- protocolSection.statusModule.overallStatus
"COMPLETED"- protocolSection.designModule.phases
["PHASE4"]- protocolSection.statusModule.resultsFirstPostDateStruct.date
""
Study condition terms
Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.
This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.